147 related articles for article (PubMed ID: 6238218)
1. Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
Adami S; Guarrera G; Salvagno G; Spiazzi G; Marini G; Rosini S; Lo Cascio V
Metab Bone Dis Relat Res; 1984; 5(6):265-7. PubMed ID: 6238218
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Delmas PD; Chapuy MC; Meunier PJ
Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
[TBL] [Abstract][Full Text] [Related]
4. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
Chapuy MC; Charhon SA; Meunier PJ
Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
[TBL] [Abstract][Full Text] [Related]
5. Effects of disodium dichloromethylene diphosphonate (CL2MDP) on Paget's disease of bone.
Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Vignon E; Trechsel U; Mathieu L; Edouard C
Adv Exp Med Biol; 1980; 128():299-309. PubMed ID: 6448538
[No Abstract] [Full Text] [Related]
6. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ
J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781
[TBL] [Abstract][Full Text] [Related]
7. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
[TBL] [Abstract][Full Text] [Related]
8. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
[TBL] [Abstract][Full Text] [Related]
9. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG
Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
Adami S; Salvagno G; Guarrera G; Montesanti F; Garavelli S; Rosini S; Lo Cascio V
Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663
[TBL] [Abstract][Full Text] [Related]
11. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
[TBL] [Abstract][Full Text] [Related]
12. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Yates AJ; Percival RC; Gray RE; Atkins RM; Urwin GH; Hamdy NA; Preston CJ; Beneton MN; Russell RG; Kanis JA
Lancet; 1985 Jun; 1(8444):1474-7. PubMed ID: 2861411
[TBL] [Abstract][Full Text] [Related]
13. [Calcitonin nasal spray for Paget's disease of the bone].
Luboshitzky R; Bar-Shalom R
Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
[TBL] [Abstract][Full Text] [Related]
14. The cardiovascular system in Paget's disease of bone and the response to therapy with calcitonin and diphosphonate.
Henley JW; Croxson RS; Ibbertson HK
Aust N Z J Med; 1979 Aug; 9(4):390-7. PubMed ID: 292378
[No Abstract] [Full Text] [Related]
15. Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease.
Harris ST; Neer RM; Segre GV; Petkau AJ; Tully GL; Daly M; Potts JT
J Clin Endocrinol Metab; 1982 Dec; 55(6):1100-7. PubMed ID: 6215419
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
Bone; 1985; 6(2):69-72. PubMed ID: 2409999
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
Ziegler R; Holz G; Minne H; Delling G
Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
[No Abstract] [Full Text] [Related]
18. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Jaeger P; Bischoff-Delaloye A; Burckhardt P
Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
[TBL] [Abstract][Full Text] [Related]
19. Paget's bone disease treated with diphosphonate and calcitonin.
Hosking DJ; Bijvoet OL; van Aken J; Will EJ
Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
[TBL] [Abstract][Full Text] [Related]
20. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
Atkins RM; Yates AJ; Gray RE; Urwin GH; Hamdy NA; Beneton MN; Rosini S; Kanis JA
J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
